Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
14,035,321
-
Share change
-
-3,616,050
-
Total reported value
-
$84,723,366
-
Put/Call ratio
-
190%
-
Price per share
-
$6.04
-
Number of holders
-
96
-
Value change
-
-$29,525,499
-
Number of buys
-
37
-
Number of sells
-
50
Institutional Holders of INSYS THERAPEUTICS INC NEW - COM NEW (INSYQ) as of Q1 2018
As of 31 Mar 2018,
INSYS THERAPEUTICS INC NEW - COM NEW (INSYQ) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,035,321 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, NORGES BANK, ETF MANAGERS GROUP, LLC, STATE STREET CORP, PANAGORA ASSET MANAGEMENT INC, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, and FMR LLC.
This page lists
96
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.